Genomic diversity contributes to the neuroinvasiveness of the Yellow fever French neurotropic vaccine

Mass vaccination with the live attenuated vaccine YF-17D is the current way to prevent infection with Yellow fever virus (YFV). However, 0.000012–0.00002% of vaccinated patients develop post-vaccination neurological syndrome (YEL-AND). Understanding the factors responsible for neuroinvasion, neurotr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakoa, Florian, Préhaud, Christophe, Beauclair, Guillaume, Chazal, Maxime, Mantel, Nathalie, Lafon, Monique, Jouvenet, Nolwenn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076279/
https://www.ncbi.nlm.nih.gov/pubmed/33903598
http://dx.doi.org/10.1038/s41541-021-00318-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076279/
https://www.ncbi.nlm.nih.gov/pubmed/33903598
http://dx.doi.org/10.1038/s41541-021-00318-3

Ejemplares similares